1203 related articles for article (PubMed ID: 25587654)
1. The JAK-STAT pathway: impact on human disease and therapeutic intervention.
O'Shea JJ; Schwartz DM; Villarino AV; Gadina M; McInnes IB; Laurence A
Annu Rev Med; 2015; 66():311-28. PubMed ID: 25587654
[TBL] [Abstract][Full Text] [Related]
2. JAKs and STATs in immunity, immunodeficiency, and cancer.
O'Shea JJ; Holland SM; Staudt LM
N Engl J Med; 2013 Jan; 368(2):161-70. PubMed ID: 23301733
[No Abstract] [Full Text] [Related]
3. JAK/STAT disruption induces immuno-deficiency: Rationale for the development of JAK inhibitors as immunosuppressive drugs.
Cornez I; Yajnanarayana SP; Wolf AM; Wolf D
Mol Cell Endocrinol; 2017 Aug; 451():88-96. PubMed ID: 28131742
[TBL] [Abstract][Full Text] [Related]
4. Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.
Tzeng HT; Chyuan IT; Lai JH
Biochem Pharmacol; 2021 Nov; 193():114760. PubMed ID: 34492272
[TBL] [Abstract][Full Text] [Related]
5. Inborn errors of human JAKs and STATs.
Casanova JL; Holland SM; Notarangelo LD
Immunity; 2012 Apr; 36(4):515-28. PubMed ID: 22520845
[TBL] [Abstract][Full Text] [Related]
6. The JAK/STAT signaling pathway: from bench to clinic.
Hu X; Li J; Fu M; Zhao X; Wang W
Signal Transduct Target Ther; 2021 Nov; 6(1):402. PubMed ID: 34824210
[TBL] [Abstract][Full Text] [Related]
7. Inteferons pen the JAK-STAT pathway.
Schindler C; Plumlee C
Semin Cell Dev Biol; 2008 Aug; 19(4):311-8. PubMed ID: 18765289
[TBL] [Abstract][Full Text] [Related]
8. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
9. Human diseases caused by impaired signal transducer and activator of transcription and Janus kinase signaling.
Chaimowitz NS; Forbes LR
Curr Opin Pediatr; 2019 Dec; 31(6):843-850. PubMed ID: 31693596
[TBL] [Abstract][Full Text] [Related]
10. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.
Xue C; Yao Q; Gu X; Shi Q; Yuan X; Chu Q; Bao Z; Lu J; Li L
Signal Transduct Target Ther; 2023 May; 8(1):204. PubMed ID: 37208335
[TBL] [Abstract][Full Text] [Related]
11. SnapShot: Jak-STAT Signaling II.
Villarino AV; Gadina M; O'Shea JJ; Kanno Y
Cell; 2020 Jun; 181(7):1696-1696.e1. PubMed ID: 32589961
[TBL] [Abstract][Full Text] [Related]
12. Tools and methods for studying the Drosophila JAK/STAT pathway.
Chen Q; Giedt M; Tang L; Harrison DA
Methods; 2014 Jun; 68(1):160-72. PubMed ID: 24685392
[TBL] [Abstract][Full Text] [Related]
13. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease.
O'Shea JJ; Plenge R
Immunity; 2012 Apr; 36(4):542-50. PubMed ID: 22520847
[TBL] [Abstract][Full Text] [Related]
14. Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy.
Mahjoor M; Mahmoudvand G; Farokhi S; Shadab A; Kashfi M; Afkhami H
Cell Commun Signal; 2023 Oct; 21(1):272. PubMed ID: 37784164
[TBL] [Abstract][Full Text] [Related]
15. Regulation of T cell homeostasis by JAKs and STATs.
Ross JA; Nagy ZS; Cheng H; Stepkowski SM; Kirken RA
Arch Immunol Ther Exp (Warsz); 2007; 55(4):231-45. PubMed ID: 17659375
[TBL] [Abstract][Full Text] [Related]
16. Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases.
Hosseini A; Gharibi T; Marofi F; Javadian M; Babaloo Z; Baradaran B
J Cell Physiol; 2020 Sep; 235(9):5903-5924. PubMed ID: 32072644
[TBL] [Abstract][Full Text] [Related]
17. JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.
Banerjee S; Biehl A; Gadina M; Hasni S; Schwartz DM
Drugs; 2017 Apr; 77(5):521-546. PubMed ID: 28255960
[TBL] [Abstract][Full Text] [Related]
18. Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis
Palmroth M; Kuuliala K; Peltomaa R; Virtanen A; Kuuliala A; Kurttila A; Kinnunen A; Leirisalo-Repo M; Silvennoinen O; Isomäki P
Front Immunol; 2021; 12():738481. PubMed ID: 34630419
[TBL] [Abstract][Full Text] [Related]
19. Molecular dissection of Janus kinases as drug targets for inflammatory diseases.
Kwon S
Front Immunol; 2022; 13():1075192. PubMed ID: 36569926
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms and consequences of Jak-STAT signaling in the immune system.
Villarino AV; Kanno Y; O'Shea JJ
Nat Immunol; 2017 Mar; 18(4):374-384. PubMed ID: 28323260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]